Literature DB >> 7686077

Management of non-functioning neuroendocrine tumours of the pancreas.

S Cheslyn-Curtis1, V Sitaram, R C Williamson.   

Abstract

Between 1982 and 1991, 20 patients of median age 44 (range 22-76) years were treated for non-functioning neuroendocrine tumours of the pancreas. Presenting features were obstructive jaundice (seven patients), abdominal pain (seven), weight loss (six), abdominal mass (eight) and severe haemorrhage (four). Gut hormone profiles were normal except for one patient who had a raised pancreatic polypeptide level. Contrast-enhanced computed tomography localized the tumour in 17 patients and visceral angiography in 14 of 15; all but three tumours were highly vascular. Ten patients underwent curative resection, and the remainder were managed palliatively by resection (four), bypass procedures (three) or biopsy alone (three). There were two postoperative deaths and seven early complications. Seven of the remaining 18 patients have died from disease a median of 16 (range 4-30) months after presentation. The 11 survivors, eight of whom had curative resections, have been followed for a median of 42 (range 7-72) months. Ten patients are asymptomatic but only five are free from disease. These tumours are seldom curable by radical surgery, but patients may remain free from symptoms for many years.

Entities:  

Mesh:

Year:  1993        PMID: 7686077     DOI: 10.1002/bjs.1800800528

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Nonfunctioning islet cell tumor with a unique pattern of tumor growth.

Authors:  K Shimizu; K Shiratori; F Toki; M Suzuki; T Imaizumi; K Takasaki; M Kobayashi; N Hayashi
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

Review 2.  Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.

Authors:  Henning Dralle; Sabine L Krohn; Wolfram Karges; Bernhard O Boehm; Michael Brauckhoff; Oliver Gimm
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

3.  Nonfunctional pancreatic neuroendocrine tumours misdiagnosed as autoimmune pancreatitis: A case report and review of literature.

Authors:  Zi-Qi Lin; Xin Li; Yan Yang; Yi Wang; Xiao-Ying Zhang; Xiao-Xin Zhang; Jia Guo
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

Review 4.  Advances in the treatment of neuroendocrine tumors.

Authors:  Matthew Kulke
Journal:  Curr Treat Options Oncol       Date:  2005-09

Review 5.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

6.  Management of nonfunctioning islet cell tumors.

Authors:  Han Liang; Pu Wang; Xiao-Na Wang; Jia-Cang Wang; Xi-Shan Hao
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

7.  Resection of the pancreatic head with or without gastrectomy.

Authors:  P Watanapa; R C Williamson
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

8.  Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franco Grimaldi; Nicola Fazio; Roberto Attanasio; Andrea Frasoldati; Enrico Papini; Francesco Angelini; Roberto Baldelli; Debora Berretti; Sara Bianchetti; Giancarlo Bizzarri; Marco Caputo; Roberto Castello; Nadia Cremonini; Anna Crescenzi; Maria Vittoria Davì; Angela Valentina D'Elia; Antongiulio Faggiano; Stefano Pizzolitto; Annibale Versari; Michele Zini; Guido Rindi; Kjell Oberg
Journal:  J Endocrinol Invest       Date:  2014-07-20       Impact factor: 4.256

9.  GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT.

Authors:  A O Oladejo
Journal:  Ann Ib Postgrad Med       Date:  2009-12

10.  Treatment options for PNET liver metastases: a systematic review.

Authors:  Giuseppe Nigri; Niccolò Petrucciani; Tarek Debs; Livia Maria Mangogna; Anna Crovetto; Giovanni Moschetta; Raffaello Persechino; Paolo Aurello; Giovanni Ramacciato
Journal:  World J Surg Oncol       Date:  2018-07-14       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.